BackInVitro International Overview

InVitro International EBIT

InVitro International's EBIT is $43K, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$830.00
↓ 98.21% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$43.25K
↓ 64.65% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

InVitro International (IVRO) FAQ

As of the most recent data (June 2026), IVRO shows a EBIT of $43K. That compares with $120K in the prior-year period — down 64.6% year over year. That is below the sector sector average of $2.4T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IVRO's EBIT is now $43K (was $120K) — a 64.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether InVitro International is outperforming or lagging.

The its sector sector average EBIT is about $2.4T. InVitro International is at $43K, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how IVRO stacks up against individual peers as well.

Tracking IVRO's ebit over time shows whether InVitro International is scaling, shrinking, or reshaping that part of the business. The current reading is $43K That compares with $120K in the prior-year period — down 64.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has InVitro International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $43K) with ownership activity and broader fundamentals.